查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2024493

整形外科軟組織修復市場報告：按手術方式、損傷部位、最終用戶和地區分類（2026-2034 年）

Orthopedic Soft Tissue Repair Market Report by Procedure, Injury Location, End User, and Region 2026-2034
出版日期: | 出版商: IMARC | 英文 150 Pages | 商品交期: 2-3個工作天內

價格

2025年，全球整形外科軟組織修復市場規模達39億美元。展望未來，IMARC Group預測，到2034年，該市場規模將達到55億美元，2026年至2034年的複合年成長率為3.78%。人口老化加劇、醫療領域技術的不斷進步以及體育活動參與度的提高是推動市場成長的主要因素。

整形外科軟組織修復市場的發展趨勢：

整形外科損傷發生率增加

整形外科損傷發生率的不斷上升是推動整形外科軟組織修復市場成長的主要動力。體育活動的增加和運動參與度的提高加劇了整形外科損傷的發生率。根據美國國家運動訓練師協會（NATA）統計，2022年美國約有3000萬名兒童參加了有組織的體育運動。隨著青少年運動聯盟的日益普及，這一數字逐年成長。反過來，這又導致了運動相關傷害的進一步增加。例如，根據美國疾病管制與預防中心（CDC）發表的報導，美國每年有超過350萬例運動相關傷害。

此外，2022年加拿大的一項研究表明，加拿大高中參與對抗性運動的學生中，相當一部分人會受傷。研究也發現，不同運動項目的受傷率差異很大，從橄欖球的每百人每年12.7例到冰球的每百人每年33.1例不等。其中，頭部受傷佔33.3%，手腕或手部受傷佔16.0%，肩部受傷佔12.8%，膝蓋受傷佔12.0%。這些損傷的嚴重不一。隨著人們身體活動的增加和運動量的增加，他們更容易遭受軟組織損傷。這些損傷包括韌帶斷裂和肌腱斷裂等，有些可能需要手術修復。

此外，人口老化和骨關節炎等慢性疾病盛行率的上升，推動了包括軟組織修復在內的整形外科手術需求的成長。例如，克利夫蘭診所的一篇報導指出，超過80%的55歲以上成年人患有骨關節炎。此外，人們對整形外科健康重要性的認知不斷提高，以及醫學知識的進步，導致尋求整形外科損傷治療的人數增加，進而推動了軟組織修復手術的需求。這些因素正在促進整形外科軟組織市場的收入成長。

人口老化和肥胖率急劇上升

人口老化和慢性病發病率上升正顯著推動軟組織修復市場的發展。例如，世界衛生組織（WHO）預測，到2030年，全球六分之一的人口將達到或超過60歲。屆時，60歲及以上人口預計將從2020年的10億增加到14億。

預計到2050年，全球60歲以上人口將翻倍，達到21億人。 80歲及以上人口預計將在2020年至2050年間成長兩倍，達到4.26億。肥胖率的顯著上升導致糖尿病、心血管疾病和腎臟疾病等慢性病的發生率增加。

例如，根據世界衛生組織（世衛組織）2023年的報告，2014年18歲及以上成年人中，糖尿病盛行率為8.5%。 2019年，糖尿病直接導致150萬人死亡，其中48%的死亡病例發生在70歲以下的人。糖尿病也導致46萬人死於腎臟疾病，高血糖約佔心血管疾病死亡病例的20%。 2000年至2019年間，經年齡已調整的糖尿病死亡率上升了3%。中低收入國家的糖尿病相關死亡率上升了13%。

此外，根據美國整形外科學會發表的一篇論文，肥胖通常與骨關節炎相關，骨關節炎是一種以軟組織損傷、關節退化和磨損為特徵的疾病。肥胖對髖關節和膝關節的骨關節炎有顯著影響。人體每增加一磅體重，每個膝關節就會承受4到6磅的壓力。肥胖患者需要全膝關節關節重建手術的可能性是非肥胖患者的20倍。這些因素進一步推動了整形外科軟組織修復市場佔有率的成長。

技術進步

技術進步在推動整形外科軟組織修復市場成長方面發揮著至關重要的作用。這些進步有助於開發更有效、創傷更小的治療方法，從而改善患者預後並縮短復原時間。此外，技術創新也促成了關節鏡和腹腔鏡等微創手術技術的發展。與傳統開放性手術相比，這些技術可以減少對周圍組織的損傷，最大限度地減少疤痕，並縮短復原時間。例如，2023年7月，全球醫療技術公司史密斯醫療（Smith & Nephew）在印度推出了其REGENETEN生物誘導植入。

REGENETEN植入徹底改變了外科醫師進行肩旋板手術的方式。自上市以來，全球已完成超過10萬例手術。 REGENETEN生物誘導植入主要成分為膠原蛋白，能夠刺激人體自身的癒合反應，促進新的肌腱樣組織的形成，從而自然地強化現有肌腱並延緩疾病進展。這些植入大小與郵票相仿，透過關節鏡手術，在肩迴旋肌損傷部位上方做一個小切口即可植入。

此外，各大公司的多項研發成果也推動了組織修復需求的成長。例如，2021年8月，骨科植入物公司宣布其DRPX腕部骨折鋼板獲得FDA核准。本產品採用II型陽極氧化鈦，並以薄鋼板和螺絲設計為特色，旨在減輕軟組織壓力。這些因素都對整形外科軟組織修復市場的前景產生了正面影響。

目錄

第1章：序言

第2章：調查方法

  • 調查目的
  • 相關利益者
  • 數據來源
    • 主要訊息
    • 次要訊息
  • 市場估值
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第3章執行摘要

第4章：引言

第5章：全球整形外科軟組織修復市場

  • 市場概覽
  • 市場表現
  • 新冠疫情的影響
  • 市場預測

第6章 市場區隔：依治療方式分類

  • 十字韌帶修復手術
  • 肩旋板修復
  • 肱骨外上髁炎修復
  • 跟腱炎修復手術
  • 骨盆器官脫垂修復手術
  • 臀肌腱修復手術
  • 髖關節鏡檢查
  • 肱二頭肌腱固定手術
  • 其他

第7章 市場區隔：依受傷部位分類

  • 膝蓋
  • 肩膀
  • 髖關節
  • 小關節

第8章 市場區隔：依最終用戶分類

  • 醫院
  • 門診部
  • 整形外科診所

第9章 市場區隔：依地區分類

  • 北美洲
    • 美國
    • 加拿大
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲

第10章 SWOT 分析

第11章：價值鏈分析

第12章：波特五力分析

第13章：價格分析

第14章 競爭格局

  • 市場結構
  • 大公司
  • 主要公司簡介
    • Arthrex Inc.
    • Becton Dickinson and Company
    • Boston Scientific Corporation
    • CONMED Corporation
    • Integra LifeSciences
    • Johnson & Johnson
    • LifeNet Health
    • MTF Biologics
    • Smith & Nephew plc
    • Stryker Corporation
    • Tissue Regenix Group plc
    • Zimmer Biomet
Product Code: SR112026A5807

The global orthopedic soft tissue repair market size reached USD 3.9 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 5.5 Billion by 2034, exhibiting a growth rate (CAGR) of 3.78% during 2026-2034. The rising geriatric population, continuous technological advancements in the medical sector, growing participation in sports activities, etc., are some of the major factors propelling the market growth.

Orthopedic Soft Tissue Repair Market Analysis:

  • Major Market Drivers: The growing participation of individuals in professional sports has significantly increased the risks of sports-related injuries, which, in turn, is facilitating the orthopedic soft tissue repair market demand. Moreover, the introduction of new therapies, such as platelet-rich plasma, that are effective in managing complex neuromuscular pain caused due to orthopedic ligament tears is proliferating the industry's growth.
  • Key Market Trends: The increasing penetration of advanced technologies, including bioprinting, biological meshes, and bio-fabrication is anticipated to proliferate the orthopedic soft tissue repair market demand. In addition, extensive research and development (R&D) activities, innovations in new devices and therapies, and increasing healthcare per capita expenditure, are also contributing to the market growth.
  • Competitive Landscape: Some of the leading orthopedic soft tissue repair market companies are Arthrex Inc., Becton Dickinson and Company, Boston Scientific Corporation, CONMED Corporation, Integra LifeSciences, Johnson & Johnson, LifeNet Health, MTF Biologics, Smith & Nephew plc, Stryker Corporation, Tissue Regenix Group plc, and Zimmer Biomet, among others.
  • Geographical Trends: The North America and Europe markets hold prominent shares of the orthopedic soft tissue repair market. Numerous factors, such as a large aging population, high prevalence of sports-related injuries, advanced healthcare infrastructure, and robust reimbursement systems, contribute to the market growth in these regions. Moreover, in the Asia Pacific region, improving healthcare infrastructures, rising disposable incomes, and growing awareness of advanced treatment options drive the market expansion.
  • Challenges and Opportunities: Cost containment of soft tissue procedures, regulatory hurdles, technological complexity, and high competition among key players are some of the major challenges that the market is facing. However, ongoing research and development efforts lead to the development of innovative technologies and biomaterials for soft tissue repair, improving procedural outcomes and patient recovery times, thereby escalating the industry demand.

Orthopedic Soft Tissue Repair Market Trends:

Rising Incidences of Orthopedic Injuries

The increasing occurrence of orthopedic injuries is significantly propelling the orthopedic soft tissue repair market forward. Rising participation in physical activities and sports is leading to a rise in the incidence of orthopedic injuries. According to the National Athletic Trainers' Association, around 30 million children participated in organized sports in the United States in 2022. This figure has risen over time, as youth sports leagues have grown in popularity. This is further escalating the number of sports injuries. For instance, according to an article published by the Centers for Disease Control and Prevention (CDC), over 3.5 million sports-related injuries occur each year in the United States.

In addition to this, a study conducted in Canada in 2022 revealed a significant percentage of injuries among contact sports participants in Canadian high schools. The survey also found that injury rates varied from 12.7 per 100 participants per year in rugby to 33.1 per 100 participants per year in ice hockey. The prevalence rate of head injuries was 33.3%; wrist or hand injuries were 16.0%; shoulder injuries were 12.8%; and knee injuries were 12.0%. This covers both minor and catastrophic injuries. As people engage in more physical activities and sports, the likelihood of sustaining soft tissue injuries rises. These injuries can range from ligament tears to tendon ruptures, requiring surgical intervention for repair.

Apart from this, the aging population, coupled with a higher prevalence of chronic conditions such as osteoarthritis, also drives the demand for orthopedic interventions, including soft tissue repair. For instance, according to an article published by the Cleveland Clinic, more than 80% of adults older than 55 had osteoarthritis. Furthermore, with growing awareness about the importance of orthopedic health and advancements in medical knowledge, more people are seeking treatment for orthopedic injuries, driving the demand for soft tissue repair procedures. These factors are bolstering the orthopedic soft tissue market revenue.

Escalating Geriatric Population and Obesity Rates

The rise in the aging population and chronic disease occurrences is significantly driving the soft tissue repair market. For instance, according to the World Health Organization, by 2030, one in every six persons in the world will be 60 or older. At this time, the proportion of the population aged 60 and up would rise from 1 billion in 2020 to 1.4 billion.

By 2050, the global population of people aged 60 and up would double (2.1 billion). The number of people aged 80 and older was anticipated to treble between 2020 and 2050, reaching 426 million. The significant rise in obesity rates is leading to the increasing incidence of chronic diseases such as diabetes, and cardiovascular and kidney-related illnesses.

For instance, according to a report published by the World Health Organization in 2023, in 2014, 8.5% of adults aged 18 and up had diabetes. In 2019, diabetes was the direct cause of 1.5 million fatalities, with 48% occurring before the age of 70. Diabetes caused an additional 460,000 renal disease deaths, and high blood glucose was responsible for approximately 20% of cardiovascular fatalities. Between 2000 and 2019, age-standardized diabetes mortality rates increased by 3%. Diabetes-related mortality has increased by 13% in low- and middle-income nations.

Moreover, according to an article published by the American Academy of Orthopedic Surgeons, obesity is usually associated with soft tissue injury and osteoarthritis, a degenerative wear and tear condition of the joints. Obesity has a significant impact on osteoarthritis of the hip and knee joints. Every pound of human weight applies four to six pounds of pressure on each knee joint. Obese people are 20 times more likely to require a knee replacement than those who are not overweight. These factors are further contributing to the orthopedic soft tissue repair market share.

Technological Advancements

Technological advancements play a crucial role in driving the growth of the orthopedic soft tissue repair market. These advancements contribute to the development of more effective and less invasive treatment options, enhancing patient outcomes and reducing recovery times. Moreover, technological innovations have led to the development of minimally invasive surgical techniques, such as arthroscopy and laparoscopy, which reduce trauma to surrounding tissues, minimize scarring, and accelerate recovery times compared to traditional open surgeries. For instance, in July 2023, Smith+Nephew, the worldwide medical technology business, launched REGENETEN bioinductive implant in India.

The REGENETEN implant has transformed the way surgeons approach rotator cuff surgeries, with over 100,000 procedures conducted globally since its inception. The collagen-based REGENETEN bioinductive implant stimulated the body's natural healing response, allowing the development of new tendon-like tissue to naturally enhance the current tendon and alter disease progression. The implant, roughly the size of a postage stamp is delivered arthroscopically through a small incision over the region of the rotator cuff tendon injury.

Apart from this, various developments by the key players are also enhancing the demand for tissue repair. For example, in August 2021, Orthopaedic Implant Company introduced its FDA-cleared DRPX wrist fracture plate, which features type II anodized titanium and a low-profile plate and screw design to reduce soft tissue impingement. These factors are positively influencing the orthopedic soft tissue repair market forecast.

Orthopedic Soft Tissue Repair Industry Segmentation:

The research provides an analysis of the key trends in each segment of the global orthopedic soft tissue repair market report, along with forecasts at the global, regional, and country levels from 2026-2034. Our report has categorized the market based on procedure, injury location, and end user.

Breakup by Procedure:

  • Cruciate Ligaments Repair
  • Rotator Cuff Repair
  • Lateral Epicondylitis
  • Achilles Tendinosis Repair
  • Pelvic Organ Prolapse
  • Gluteal Tendon Repair
  • Hip Arthroscopy
  • Biceps Tenodesis
  • Others

According to the orthopedic soft tissue repair market outlook, cruciate ligaments repair is commonly performed to reconstruct a torn anterior cruciate ligament (ACL) in the knee, which often occurs during sports injuries. Demand for this procedure tends to be consistent due to the prevalence of sports-related injuries. While rotator cuff repair is a group of muscles and tendons that stabilize the shoulder joint. Tears in the rotator cuff are common, especially among older adults and athletes engaged in overhead activities.

The demand for rotator cuff repair remains steady due to the aging population and continued participation in sports. Moreover, lateral epicondylitis, commonly known as tennis elbow, is inflammation of the tendons that join the forearm muscles on the outside of the elbow. Treatment options include conservative measures like rest, physical therapy, and corticosteroid injections, but in some cases, surgical intervention may be necessary.

Breakup by Injury Location:

  • Knee
  • Shoulder
  • Hip
  • Small Joints

According to the orthopedic soft tissue repair market outlook, the demand for soft tissue repair procedures in the knee, shoulder, hip, and small joints can vary based on several factors, including the prevalence of injuries, demographic trends, advancements in surgical techniques, and changes in patient preferences. There has been a noted increase in the incidence of ACL knee tears, especially among young athletes participating in high-impact sports like soccer, basketball, and football.

Factors contributing to this rise may include increased sports participation, year-round training, and higher intensity levels. Moreover, there has been a rise in rotator cuff injuries in the shoulder, particularly among individuals over 40, possibly due to aging demographics, increased sports participation among older adults, and occupational demands.

Breakup by End User:

  • Hospitals
  • Ambulatory Centers
  • Orthopedic Clinics

Hospitals often handle acute soft tissue injuries requiring immediate attention, such as traumatic ligament tears, tendon ruptures, or severe joint dislocations. Soft tissue repair procedures performed in hospitals may include complex surgeries or revisions. Hospitals can accommodate patients requiring overnight stays or post-operative monitoring, which may be necessary for certain soft tissue repair procedures with extended recovery periods or higher risk profiles.

Moreover, ASCs are increasingly popular for performing elective soft tissue repair procedures that do not require overnight hospitalization, such as arthroscopic surgeries for meniscal tears or rotator cuff repairs. Apart from this, orthopedic clinics focus exclusively on musculoskeletal conditions and surgeries, including soft tissue repair procedures. Patients seeking specialized orthopedic care may prefer these clinics for comprehensive evaluations, treatment planning, and post-operative rehabilitation.

Breakup by Region:

  • North America
  • United States
  • Canada
  • Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa

The market research report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa.

According to the orthopedic soft tissue market statistics, the North America region, including the United States and Canada, has well-established medical systems with high levels of healthcare expenditure. Factors such as a large aging population, increasing sports participation, and advancements in medical technology drive the demand for orthopedic soft tissue repair procedures.

Moreover, in Europe, countries like Germany, France, and the United Kingdom, have sophisticated healthcare infrastructure and high demand for orthopedic procedures. Additionally, the orthopedic soft tissue repair market in the Asia Pacific region is rapidly expanding due to urbanization, the aging population, and increasing healthcare expenditures. The government's healthcare reforms and investments in medical infrastructure further boost the market growth.

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players that are:

  • Arthrex Inc.
  • Becton Dickinson and Company
  • Boston Scientific Corporation
  • CONMED Corporation
  • Integra LifeSciences
  • Johnson & Johnson
  • LifeNet Health
  • MTF Biologics
  • Smith & Nephew plc
  • Stryker Corporation
  • Tissue Regenix Group plc
  • Zimmer Biome.

Key Questions Answered in This Report

  • How big is the orthopedic soft tissue repair market?
  • What is the future outlook of orthopedic soft tissue repair market?
  • What are the key factors driving the orthopedic soft tissue repair market?
  • Which region accounts for the largest orthopedic soft tissue repair market share?
  • Which are the leading companies in the global orthopedic soft tissue repair market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Orthopedic Soft Tissue Repair Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Procedure

  • 6.1 Cruciate Ligaments Repair
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Rotator Cuff Repair
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Lateral Epicondylitis
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Achilles Tendinosis Repair
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast
  • 6.5 Pelvic Organ Prolapse
    • 6.5.1 Market Trends
    • 6.5.2 Market Forecast
  • 6.6 Gluteal Tendon Repair
    • 6.6.1 Market Trends
    • 6.6.2 Market Forecast
  • 6.7 Hip Arthroscopy
    • 6.7.1 Market Trends
    • 6.7.2 Market Forecast
  • 6.8 Biceps Tenodesis
    • 6.8.1 Market Trends
    • 6.8.2 Market Forecast
  • 6.9 Others
    • 6.9.1 Market Trends
    • 6.9.2 Market Forecast

7 Market Breakup by Injury Location

  • 7.1 Knee
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Shoulder
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Hip
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Small Joints
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast

8 Market Breakup by End User

  • 8.1 Hospitals
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Ambulatory Centers
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Orthopedic Clinics
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Arthrex Inc.
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 SWOT Analysis
    • 14.3.2 Becton Dickinson and Company
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 Financials
      • 14.3.2.4 SWOT Analysis
    • 14.3.3 Boston Scientific Corporation
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
    • 14.3.4 CONMED Corporation
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
      • 14.3.4.4 SWOT Analysis
    • 14.3.5 Integra LifeSciences
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 Financials
      • 14.3.5.4 SWOT Analysis
    • 14.3.6 Johnson & Johnson
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
      • 14.3.6.4 SWOT Analysis
    • 14.3.7 LifeNet Health
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
    • 14.3.8 MTF Biologics
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
    • 14.3.9 Smith & Nephew plc
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
      • 14.3.9.3 Financials
    • 14.3.10 Stryker Corporation
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
      • 14.3.10.3 Financials
      • 14.3.10.4 SWOT Analysis
    • 14.3.11 Tissue Regenix Group plc
      • 14.3.11.1 Company Overview
      • 14.3.11.2 Product Portfolio
      • 14.3.11.3 Financials
    • 14.3.12 Zimmer Biomet
      • 14.3.12.1 Company Overview
      • 14.3.12.2 Product Portfolio
      • 14.3.12.3 Financials
      • 14.3.12.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Orthopedic Soft Tissue Repair Market: Major Drivers and Challenges
  • Figure 2: Global: Orthopedic Soft Tissue Repair Market: Sales Value (in Billion USD), 2020-2025
  • Figure 3: Global: Orthopedic Soft Tissue Repair Market Forecast: Sales Value (in Billion USD), 2026-2034
  • Figure 4: Global: Orthopedic Soft Tissue Repair Market: Breakup by Procedure (in %), 2025
  • Figure 5: Global: Orthopedic Soft Tissue Repair Market: Breakup by Injury Location (in %), 2025
  • Figure 6: Global: Orthopedic Soft Tissue Repair Market: Breakup by End User (in %), 2025
  • Figure 7: Global: Orthopedic Soft Tissue Repair Market: Breakup by Region (in %), 2025
  • Figure 8: Global: Orthopedic Soft Tissue Repair (Cruciate Ligaments Repair) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 9: Global: Orthopedic Soft Tissue Repair (Cruciate Ligaments Repair) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 10: Global: Orthopedic Soft Tissue Repair (Rotator Cuff Repair) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 11: Global: Orthopedic Soft Tissue Repair (Rotator Cuff Repair) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 12: Global: Orthopedic Soft Tissue Repair (Lateral Epicondylitis) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 13: Global: Orthopedic Soft Tissue Repair (Lateral Epicondylitis) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 14: Global: Orthopedic Soft Tissue Repair (Achilles Tendinosis Repair) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 15: Global: Orthopedic Soft Tissue Repair (Achilles Tendinosis Repair) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 16: Global: Orthopedic Soft Tissue Repair (Pelvic Organ Prolapse) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 17: Global: Orthopedic Soft Tissue Repair (Pelvic Organ Prolapse) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 18: Global: Orthopedic Soft Tissue Repair (Gluteal Tendon Repair) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 19: Global: Orthopedic Soft Tissue Repair (Gluteal Tendon Repair) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 20: Global: Orthopedic Soft Tissue Repair (Hip Arthroscopy) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 21: Global: Orthopedic Soft Tissue Repair (Hip Arthroscopy) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 22: Global: Orthopedic Soft Tissue Repair (Biceps Tenodesis) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 23: Global: Orthopedic Soft Tissue Repair (Biceps Tenodesis) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 24: Global: Orthopedic Soft Tissue Repair (Other Procedures) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 25: Global: Orthopedic Soft Tissue Repair (Other Procedures) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 26: Global: Orthopedic Soft Tissue Repair (Knee) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 27: Global: Orthopedic Soft Tissue Repair (Knee) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 28: Global: Orthopedic Soft Tissue Repair (Shoulder) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 29: Global: Orthopedic Soft Tissue Repair (Shoulder) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 30: Global: Orthopedic Soft Tissue Repair (Hip) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 31: Global: Orthopedic Soft Tissue Repair (Hip) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 32: Global: Orthopedic Soft Tissue Repair (Small Joints) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 33: Global: Orthopedic Soft Tissue Repair (Small Joints) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 34: Global: Orthopedic Soft Tissue Repair (Hospitals) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 35: Global: Orthopedic Soft Tissue Repair (Hospitals) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 36: Global: Orthopedic Soft Tissue Repair (Ambulatory Centers) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 37: Global: Orthopedic Soft Tissue Repair (Ambulatory Centers) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 38: Global: Orthopedic Soft Tissue Repair (Orthopedic Clinics) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 39: Global: Orthopedic Soft Tissue Repair (Orthopedic Clinics) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 40: North America: Orthopedic Soft Tissue Repair Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 41: North America: Orthopedic Soft Tissue Repair Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 42: United States: Orthopedic Soft Tissue Repair Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 43: United States: Orthopedic Soft Tissue Repair Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 44: Canada: Orthopedic Soft Tissue Repair Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 45: Canada: Orthopedic Soft Tissue Repair Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 46: Asia-Pacific: Orthopedic Soft Tissue Repair Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 47: Asia-Pacific: Orthopedic Soft Tissue Repair Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 48: China: Orthopedic Soft Tissue Repair Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 49: China: Orthopedic Soft Tissue Repair Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 50: Japan: Orthopedic Soft Tissue Repair Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 51: Japan: Orthopedic Soft Tissue Repair Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 52: India: Orthopedic Soft Tissue Repair Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 53: India: Orthopedic Soft Tissue Repair Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 54: South Korea: Orthopedic Soft Tissue Repair Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 55: South Korea: Orthopedic Soft Tissue Repair Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 56: Australia: Orthopedic Soft Tissue Repair Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 57: Australia: Orthopedic Soft Tissue Repair Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 58: Indonesia: Orthopedic Soft Tissue Repair Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 59: Indonesia: Orthopedic Soft Tissue Repair Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 60: Others: Orthopedic Soft Tissue Repair Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 61: Others: Orthopedic Soft Tissue Repair Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 62: Europe: Orthopedic Soft Tissue Repair Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 63: Europe: Orthopedic Soft Tissue Repair Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 64: Germany: Orthopedic Soft Tissue Repair Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 65: Germany: Orthopedic Soft Tissue Repair Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 66: France: Orthopedic Soft Tissue Repair Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 67: France: Orthopedic Soft Tissue Repair Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 68: United Kingdom: Orthopedic Soft Tissue Repair Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 69: United Kingdom: Orthopedic Soft Tissue Repair Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 70: Italy: Orthopedic Soft Tissue Repair Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 71: Italy: Orthopedic Soft Tissue Repair Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 72: Spain: Orthopedic Soft Tissue Repair Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 73: Spain: Orthopedic Soft Tissue Repair Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 74: Russia: Orthopedic Soft Tissue Repair Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 75: Russia: Orthopedic Soft Tissue Repair Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 76: Others: Orthopedic Soft Tissue Repair Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 77: Others: Orthopedic Soft Tissue Repair Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 78: Latin America: Orthopedic Soft Tissue Repair Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 79: Latin America: Orthopedic Soft Tissue Repair Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 80: Brazil: Orthopedic Soft Tissue Repair Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 81: Brazil: Orthopedic Soft Tissue Repair Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 82: Mexico: Orthopedic Soft Tissue Repair Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 83: Mexico: Orthopedic Soft Tissue Repair Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 84: Others: Orthopedic Soft Tissue Repair Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 85: Others: Orthopedic Soft Tissue Repair Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 86: Middle East and Africa: Orthopedic Soft Tissue Repair Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 87: Middle East and Africa: Orthopedic Soft Tissue Repair Market: Breakup by Country (in %), 2025
  • Figure 88: Middle East and Africa: Orthopedic Soft Tissue Repair Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 89: Global: Orthopedic Soft Tissue Repair Industry: SWOT Analysis
  • Figure 90: Global: Orthopedic Soft Tissue Repair Industry: Value Chain Analysis
  • Figure 91: Global: Orthopedic Soft Tissue Repair Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Orthopedic Soft Tissue Repair Market: Key Industry Highlights, 2025 and 2034
  • Table 2: Global: Orthopedic Soft Tissue Repair Market Forecast: Breakup by Procedure (in Million USD), 2026-2034
  • Table 3: Global: Orthopedic Soft Tissue Repair Market Forecast: Breakup by Injury Location (in Million USD), 2026-2034
  • Table 4: Global: Orthopedic Soft Tissue Repair Market Forecast: Breakup by End User (in Million USD), 2026-2034
  • Table 5: Global: Orthopedic Soft Tissue Repair Market Forecast: Breakup by Region (in Million USD), 2026-2034
  • Table 6: Global: Orthopedic Soft Tissue Repair Market: Competitive Structure
  • Table 7: Global: Orthopedic Soft Tissue Repair Market: Key Players